Degarelix Superior to Leuprolide, Study Finds - Renal and Urology News PDF Print
Renal and Urology News
“The long-term data support the durability of the significant progression-free survival benefit for degarelix treatment over monthly leuprolide seen during the first treatment year,” Dr. Shore told Renal & Urology News. Additionally, he noted, these

...

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.